冠心宁注射液关节腔注射辅助治疗股骨头坏死的研究

Study on the adjuvant treatment of femoral head necrosis with Guanxinning injection into the joint cavity

ES评分 0

DOI 10.12208/j.ijcr.20240415
刊名
International Journal of Clinical Research
年,卷(期) 2024, 8(10)
作者
作者单位

1 渭南市骨科医院 陕西渭南 ;
2 西京医院 陕西西安 ;

摘要
探究冠心宁注射液关节腔注射辅助治疗股骨头坏死的效果。方法 选取2023.1-2023.12期间我院收治的股骨头坏死患者80例,按照数字随机法分为对照组和观察组,每组各40例患者,对照组使用氟比洛芬酯注射液进行治疗,观察组在对照组的基础上,加入冠心宁注射液辅助治疗,对比两组治疗后的髋关节功能和疼痛程度。结果 观察组的髋关节功能明显优于对照组,差异具有统计学意义(p<0.05);观察组的疼痛程度明显轻于对照组,差异具有统计学意义(p<0.05)。结论 冠心宁注射液关节腔注射辅助治疗股骨头坏死有显著效果,能够有效地改善患者的髋关节功能,减轻疼痛程度,值得临床实践应用。
Abstract
Objective A study on the adjuvant treatment of femoral head necrosis with joint cavity injection of Guanxinning injection. Methods Select 80 patients with femoral head necrosis admitted to our hospital from January 2023 to December 2023, and randomly divide them into a control group and an observation group according to the numerical randomization method, with 40 patients in each group. The control group is treated with flurbiprofen axetil injection, while the observation group is treated with Guanxinning injection as an adjuvant therapy on the basis of the control group. Compare the hip joint function and pain level of the two groups after treatment. Results The hip joint function of the observation group was significantly better than that of the control group, and the difference was statistically significant (p<0.05); The pain level in the observation group was significantly milder than that in the control group, and the difference was statistically significant (p<0.05). Conclusion The joint cavity injection of Guanxinning injection has a significant effect on the adjuvant treatment of femoral head necrosis, which can effectively improve hip joint function and alleviate pain in patients, and is worthy of clinical practice application.
关键词
冠心宁注射液;辅助治疗;股骨头坏死;氟比洛芬酯注射液
KeyWord
Guanxinning Injection; Adjuvant therapy; Femoral head necrosis; Aspirin
基金项目
页码 83-85
  • 参考文献
  • 相关文献
  • 引用本文

赵妮*,李杜鹏. 冠心宁注射液关节腔注射辅助治疗股骨头坏死的研究 [J]. 国际临床研究杂志. 2024; 8; (10). 83 - 85.

  • 文献评论

相关学者

相关机构